Neuroscientific Biopharmaceuticals Ltd is a limited by shares Australian public company. Located at WA 6011 since 2020-09-17 the company is, as the updated on 2023-05-04 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2004-09-01. Known company numbers for Neuroscientific Biopharmaceuticals Ltd are as follows: ACN - 102832995, Australian Business Number - 13102832995. Neuroscientific Biopharmaceuticals Ltd has been the company name since 2018-07-25. Neuroscientific Biopharmaceuticals is an example of a business name Neuroscientific Biopharmaceuticals Ltd used. The complete list includes 1 solitary business name. Neuroscientific Biopharmaceuticals was the company's business name from 2016-07-05 until 2023-05-04. Their official company name changed on 2016-10-25 to Neuroscientific Biopharmaceuticals Pty Ltd. The company had used this name up until 2017-11-30. Additionally they had used Alzhyme Pty Ltd from 2002-11-15 to 2016-10-25. This Australian public company was previously located in WA 6009 (from 2016-11-11 to 2020-09-17), WA 6102 (from 2010-02-01 to 2016-11-11), WA 6000 (from 2002-11-15 to 2010-02-01).
Status | From | To |
---|---|---|
Active | Friday 15th November 2002 | current |
Name | From | To |
---|---|---|
Neuroscientific Biopharmaceuticals Ltd | Thursday 30th November 2017 | current |
Neuroscientific Biopharmaceuticals Pty Ltd | Tuesday 25th October 2016 | Thursday 30th November 2017 |
Alzhyme Pty Ltd | Friday 15th November 2002 | Tuesday 25th October 2016 |
Name | From | To |
---|---|---|
Neuroscientific Biopharmaceuticals | Tuesday 5th July 2016 | Thursday 4th May 2023 |
Location | From | To |
---|---|---|
WA 6011 | Thursday 17th September 2020 | current |
WA 6009 | Friday 11th November 2016 | Thursday 17th September 2020 |
WA 6102 | Monday 1st February 2010 | Friday 11th November 2016 |
WA 6000 | Friday 15th November 2002 | Monday 1st February 2010 |
Status | From | To |
---|---|---|
Registered | Wednesday 1st September 2004 | current |
Registered | Friday 15th November 2002 | current |
Advertisements
General information:
Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | G01N 33/68 |
Section code: | G - physics |
Class code: | 1 - measuring; testing |
Subclass code: | N - investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or micro-organisms c12m, c12q) |
Main group code: | 33 - investigating or analysing materials by specific methods not covered by groups ; g01n0001000000-g01n0031000000 |
Subgroup code: | 68 - involving proteins, peptides or amino acids |
IP Australia process information:
Expiry date: | Friday 30th December 2022 |
General information:
Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | A61P 25/28 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
Main group code: | 25 - drugs for disorders of the nervous system |
Subgroup code: | 28 - for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating alzheimer's disease or other forms of dementia |
IP Australia process information:
Expiry date: | Monday 15th November 2027 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.